Requires certain local government community benefit agreements dedicate resources for affordable housing purposes.
Impact
If enacted, S1102 would significantly adjust the framework of health insurance policies in New Jersey, particularly regarding conditions requiring glucose monitoring. This means that health insurers, including hospital service corporations, medical service corporations, health maintenance organizations, and individual/group health insurance policies, will be required by law to include this crucial coverage. This is expected to alleviate some financial burdens on families and patients needing these vital medical devices, promoting better health management and potentially reducing emergency health care expenses related to unmonitored conditions.
Summary
Senate Bill S1102 aims to enhance health insurance coverage for individuals suffering from glycogen storage disease by mandating that health benefits plans provide coverage for continuous glucose monitoring systems. The bill specifies that coverage for these monitoring systems will be treated on par with any other medical condition under the related health insurance contracts. This legislation targets a critical need for patients with glycogen storage disease to better manage their condition, which can greatly improve their quality of life and health outcomes.
Sentiment
The general sentiment surrounding S1102 has been positive, particularly among healthcare advocates and organizations supporting individuals with glycogen storage disease. Proponents argue that this bill represents an important step toward equitable health coverage for chronic conditions, emphasizing the necessity of continuous monitoring for effective disease management. However, there may be concerns from insurance companies about the increased costs associated with expanded coverage, which could lead to discussions about premium adjustments or policy changes.
Contention
While there is broad support for the bill, some legislators may express concerns about increasing healthcare costs or questions about the practical implementation of these new coverage requirements. There might also be debates regarding how effectively this mandate can be integrated into existing health insurance frameworks, especially in relation to different types of policy contracts. Overall, the discussions highlight the ongoing challenges of balancing health care accessibility with financial sustainability for insurance providers.
Requires Medicaid provide health benefits coverage, and places certain requirements on insurers and State Health Benefits Program regarding existing mandate on health benefits coverage, for certain over-the-counter contraceptives.
Providing price limits and other requirements for health benefits covering prescription insulin drugs and establishing the insulin affordability program for the uninsured.
Allows remote patient monitoring of pregnant patients; requires reimbursement for remote patient monitoring rendered to certain Medicaid beneficiaries.